Skip to content

Clomiphene Citrate Stair-Step Protocol

Clomiphene Citrate Stair-step Protocol for Ovulation Induction in Women With Polycystic Ovarian Syndrome: A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03178500
Enrollment
60
Registered
2017-06-07
Start date
2017-02-01
Completion date
2018-07-31
Last updated
2018-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary

Keywords

clomiphene citrate, stair- step, poly cystic ovary

Brief summary

A RCT will be conducted to compare the traditional clomiphene citrate regimens for ovulation induction with the stair-step protocol. Sixty women will be included after obtaining their written informed consent and will be randomized into either of the 2 groups.

Detailed description

This study is a randomized clinical trial (RCT) will be conducted in Ain Shams University maternity hospital at infertility clinic within a period of 6-8 months. All patient are previously diagnosed as PCOs according to the Rotterdam conference of 2003. All patients will be devided according to computer based program into two groups First group: Patients with traditional protocol Traditional protocol: Clomiphene citrate (clomid) (50mg) will be given for 5 days (days 3-7). Transvaginal ultrasound from 9th-20th every other day if ovulation occur the patient will be excluded if no ovulation, we will wait for the next menses and increase the dose to (100mg). if no ovulation occurred increase the dose to (150mg) in the next cycle if no ovulation increase the dose to (200mg) TVUS from 9th-20th ovary other day. If no ovulation we will wait for next cycle and increase the dose to (250mg) and so till 6 cycles . Second group: Patient with stair step protocol Follicular development will be monitored using transvaginal ultrasound at 11-14 day after (50mg) clomiphene for 5 days if there is no response (no follicle \>10mm), so, (100mg) clomiphene will be initiated immediately for 5 days and ultrasound will be repeated 1 week after the first ultrasound. If there is no response, (150mg) clomiphene will be initiated immediately for another 5 days and TV/US will be performed 1 week after the second TV/US .

Interventions

stair-step clomiphene adminstration

Sponsors

Ain Shams Maternity Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 20-35 years. * Body mass index (BMI/m2) 26-35 kg/m2 * Normal hystrosalpingogram (HSG). * Normal Prolactin level. * Normal semen analysis.

Exclusion criteria

* \- They underwent ovarian drilling. * Other factors infertility. * AUTOimmune diseases as thyroid disorders and systemic lupus erythematosus.

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of the ovulation by transvaginal ultrasound20 days* Follicle suddenly disappears or regresses in size. * Irregular margins. * Intra follicular echos. Follicle suddenly becomes more echogenic. * Free fluid in pouch of douglas.

Secondary

MeasureTime frameDescription
time to achieve ovulation20 daystime for ovulation to occur
dose of clomiphene to achieve ovulation20 daysthe total dose of clomiphene used till ovulation

Countries

Egypt

Contacts

Primary ContactAdel S Salah El-Din, MD
shafikadel@hotmail.com01005223586

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026